CHESAPEAKE UTILITIES CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CHESAPEAKE UTILITIES CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	499	450	490	480	488	570	681	671	787	930
Operating expenses	413	360	395	373	375	439	538	520	559	674
Operating income	86	89.7	94.8	106	113	131	143	151	228	256
Interest expense	10.6	12.5	16.1	22.2	21.8	20.1	24.4	36.9	68.4	72.5
Interest income							0.8
Other non-operating income	-2.33	-2.2	-0.61	-1.85	3.22	1.72	5.1	1.4	2	9.6
Pre-tax income	73	75	78.1	82.2	94.2	113	124	115	162	193
Income tax	28.3	14.7	21.1	21.1	23.5	29.2	33.8	28.1	43.2	52.7
Income from continuing operations		60.3	57	61.1	70.6	83.5	89.8
Net income	44.7	58.1	56.6	65.2	71.5	83.5	89.8	87.2	119	140
EBITDA	118	126	135	152	171	194	212	216	294	348
EPS, basic	2.87	3.56	3.46	3.97	4.28	4.75	5.07	4.75	5.28	6.00
EPS, diluted	2.86	3.55	3.45	3.96	4.26	4.73	5.04	4.73	5.26	5.97
Shares, basic (weighted)	15.6	16.3	16.4	16.4	16.7	17.6	17.7	18.4	22.5	23.4
Shares, diluted (weighted)	15.6	16.4	16.4	16.4	16.8	17.6	17.8	18.4	22.5	23.5
Dividend per share	1.20	1.28	1.44	1.59	1.59	1.88	2.09	2.31	2.51	2.70

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	4.18	5.61	6.09	6.99	3.5	4.98	6.2	4.9	7.9	1.8
Receivables	62.8	77.2	53.8	49.6	56.9	58.5	62.9	71.8	76.7	102
Other current assets	2.47	7.26	5.68	2.88	0.44	1.03	0.43	2.8	2.6	3
Total current assets	141	179	192	135	136	170	194	186	204	237
Property, plant and equipment	987	1,126	1,354	1,464	1,601	1,745	1,810	2,456	2,736	3,118
Lease right-of-use assets				11.6	11.2	10.1	14.4	12.4	10.5	9.9
Goodwill	15.1	19.6	21.6	32.7	38.7	44.7	46.2	508	508	508
Intangible assets	1.84	4.69	3.85	8.13	8.29	13.2	17.9	16.9	15	13.2
Total assets	1,229	1,415	1,694	1,783	1,932	2,115	2,215	3,305	3,577	3,995
Accounts payable	56.9	74.7	98.7	54.1	60.3	52.6	61.5	77.5	78.3	115
Accrued liabilities	10.5	13.1	13.9	16.2	14	15.5	14.7	16.5	23.9	21.6
Deferred revenue		0.41	0.48	0.59	0.64	0.75	0.98	1	1.2	1.3
Short-term debt	12.1	9.42	11.9	45.6	13.6	18	21.5	18.5	25.5	135
Total current liabilities	334	413	528	423	329	376	369	386	419	530
Long-term debt	137	197	316	440	508	550	578	1,187	1,262	1,327
Lease liabilities				9.9	9.87	8.57	12.4	10.6	8.7	7.9
Other non-current liabilities	4.75	3.46	2.97	2.8	4.9	2.14	1.41	1.3	1.4	12.5
Total liabilities	783	929	1,175	1,222	1,235	1,341	1,382	2,059	2,187	2,396
Total debt	146	205	327	487	523	569	601	1,200	1,300	1,500
Paid-in capital	251	253	256	259	348	371	380	749	831	963
Retained earnings	192	229	262	301	343	393	446	489	550	627
Treasury stock	-2.42	-3.4	-3.85	-4.54	-5.68	-7.24	-7.06	-9.1	-9.8	-12.6
Other comprehensive income	-4.88	-4.27	-6.71	-6.27	-2.87	1.3	-1.4	-2.8	-1.7	-2.7
Shareholders' equity	446	486	518	562	697	774	833	1,246	1,390	1,599
Total equity	446	486	518	562	697	774	833	1,246	1,390	1,599
Total liabilities and equity	1,229	1,415	1,694	1,783	1,932	2,115	2,215	3,305	3,577	3,995

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	44.7	58.1	56.6	65.2	71.5	83.5	89.8	87.2	119	140
Depreciation and amortization	32.2	36.4	40.2	45.4	58.1	62.7	69	65.5	65.7	91.7
Stock-based compensation	2.37	2.49	2.81	4.28	4.83	5.95	6.4	7.6	8.4	8.5
Deferred income tax	31.3	12.1	20.9	23.9	24.2	26.6	23.6	7.9	37.2	29.2
Change in receivables	-27	-19.5	-16.3	36.5	-7.43	-1.63	-11.2	2.3	-10.3	-37.1
Change in inventory	-2.53	-9.04	2.11	8.23	1.71	-9.52	-7.8	0.3	3.3	-0.6
Change in payables	19.6	15.6	35.9	-62	4.94	8.29	2.7	-16.8	0.4	13.3
Cash from operations	104	110	117	103	159	151	159	204	239	234
Capital expenditures	-170	-175	-240	-185	-166	-187	-128	-189	-355	-449
Acquisitions	0	-11.9	-16.7	-24	-22.2	-36.4	-11.8	-925	0.6	0
Cash from investing	-170	-187	-257	-187	-182	-223	-137	-1,111	-350	-436
Debt issued	0	69.8	155	200	89.8	59.5	49.9	627	99.5	199
Debt repaid	-9.15	-12.1	-34.4	-41.9	-53.6	-13.8	-18	-21.5	-18.5	-25.5
Stock issued	57.4	-0.01	0	0	61	0	0	366
Share buybacks			-0.71	-0.72	22.6	15.9	4.53
Dividends paid	-17.5	-19.9	-22	-24.7	-27.2	-31.5	-35.2	-40	-54.2	-60.7
Cash from financing	67.2	78.2	140	84.5	19.2	74	-21.2	907	114	196
Net change in cash	1.32	1.44	0.48	0.9	-3.49	1.48	1.2	-1.3	3	-6.1
Free cash flow	-65.7	-65.2	-123	-81.8	-6.6	-36.4	30.6	14.9	-116	-215
Interest paid	10.3	12.4	16.7	23.9	22.9	20.8	24.3	30.5	73	73.2
Income taxes paid	-5.31	-4.11	0.48	3.22	-8.14	8.4	-5	21.9	9.4	16

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $128.77 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	27.3%	Operating income / revenue.
EBITDA margin	36.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Net margin	15.1%	Net income / revenue.
FCF margin	-20.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	31.0%	Cash from operations / revenue.
Return on equity (ROE)	9.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.6%	Net income / average total assets.
Return on invested capital (ROIC)	6.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	51.9%	Capital expenditures / revenue.
D&A / revenue	9.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	18.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	11.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	13.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	12.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	21.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	17.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	18.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	17.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	15.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	18.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	16.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	14.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	13.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	5.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	7.0%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-2.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	13.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	8.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	7.4%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	8.9%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	11.2%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	15.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	24.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	18.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	11.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	21.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	15.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	4.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	9.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	7.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.32x	Current assets / current liabilities.
Quick ratio	0.16x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.00x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.90x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	35.9%	Total debt / total assets.
Liabilities / assets	59.9%	Total liabilities / total assets.
Net debt	$1.50B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	4.13x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	3.68x	Operating income / interest expense.
Working capital	-$406.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	12.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.15B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.24x	Revenue / average total assets.
Fixed asset turnover	0.30x	Revenue / average property, plant and equipment.
Receivables turnover	10.8x	Revenue / average receivables.
Days sales outstanding	34 days	365 x average receivables / revenue.
FCF conversion	-138.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	167.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$6.21	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$41.10	Revenue / diluted weighted shares.
FCF per share	-$8.60	Free cash flow / diluted weighted shares.
Operating cash flow per share	$12.75	Cash from operations / diluted weighted shares.
Book value per share	$69.22	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$47.71	Tangible book value / shares outstanding.
Cash per share	$0.02	(Cash + short-term investments) / shares outstanding.
Payout ratio	42.7%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$3.10B	Share price x shares outstanding.
Enterprise value	$4.60B	Market cap + total debt - cash - short-term investments.
P/E	20.7x	Market cap / net income. Only when net income is positive.
P/S	3.12x	Market cap / revenue.
P/B	1.86x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.69x	Market cap / tangible book value, when positive.
P/OCF	10.1x	Market cap / cash from operations, when positive.
EV/Sales	4.63x	Enterprise value / revenue.
EV/EBIT	17.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	12.7x	Enterprise value / EBITDA, when both are positive.
FCF yield	-6.7%	Free cash flow / market cap.
Earnings yield	4.8%	Net income / market cap (the inverse of P/E).
Dividend yield	2.1%	Dividends paid over the period / market cap.
Shareholder yield	2.1%	(Dividends paid + share buybacks) / market cap.
PEG	3.56x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was CHESAPEAKE UTILITIES CORP's revenue in fiscal 2025?

CHESAPEAKE UTILITIES CORP reported revenue of $930.0M for fiscal 2025, 18.1% higher than the year before.

Was CHESAPEAKE UTILITIES CORP profitable in fiscal 2025?

Yes. Net income was $140.3M, a net margin of 15.1%.

How much free cash flow did CHESAPEAKE UTILITIES CORP generate in fiscal 2025?

Cash from operations of $233.7M minus capital expenditures of $448.6M left free cash flow of -$214.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CHESAPEAKE UTILITIES CORP